Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Migraine in adolescents: towards an easy-to-use screening tool

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lipton RB et al. (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68: 343–349

    Article  CAS  Google Scholar 

  2. Bigal ME et al. (2007) Migraine in adolescents: association with socioeconomic status and family history. Neurology 69: 16–25

    Article  CAS  Google Scholar 

  3. Lipton RB et al. (2004) Tools for diagnosing migraine and measuring its severity. Headache 44: 387–398

    Article  Google Scholar 

  4. Lipton RB et al. (2003) A self-administered screener for migraine in primary care: the ID Migraine validation study. Neurology 61: 375–382

    Article  CAS  Google Scholar 

  5. Hershey AD et al. (2005) Use of the ICHD-II criteria in the diagnosis of pediatric migraine. Headache 45: 1288–1297

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marcelo E Bigal.

Ethics declarations

Competing interests

Marcelo Bigal is a consultant for Allergan, AstraZeneca, GlaxoSmithKline, MAP Pharmaceuticals, Merck, NMT Medical and Pfizer; he has received speaker's honoraria and grant/research support from Allergan, AstraZeneca, GlaxoSmithKline, Merck and Pfizer, and is the Global Director for Scientific Affairs at Merck.

Richard Lipton is a consultant for Advanced Bionics, Allergan, Boehringer Ingelheim, Bristol–Myers Squibb, Cierra, Endo Pharmaceuticals, GlaxoSmithKline, Neuralieve, Novartis, Ortho-McNeil, Pfizer, POZEN and ProEthics. He has received speaker's honoraria from Allergan, AstraZeneca, GlaxoSmithKline, Minster (in the form of stock), Merck, Neuralieve, Novartis, Ortho–McNeil and Pfizer, and research grants from Advanced Bionics, Allergan, GlaxoSmithKline, Minster, Merck, Neuralieve, Ortho–McNeil, Pfizer, ProEthics and St Jude Medical.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bigal, M., Lipton, R. Migraine in adolescents: towards an easy-to-use screening tool. Nat Rev Neurol 4, 246–247 (2008). https://doi.org/10.1038/ncpneuro0754

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0754

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing